Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.

Castaneda CA, Castillo M, Torres-Cabala C, Bernabe LA, Casavilca S, Villegas V, Sanchez J, de la Cruz M, Dunstan J, Cotrina JM, Gomez HL, Chavez C, Landa-Baella MP, Tello K, Felix BF, Abugattas J.

Clin Transl Oncol. 2019 Feb 16. doi: 10.1007/s12094-019-02033-x. [Epub ahead of print]


Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

Castaneda CA, Torres-Cabala C, Castillo M, Villegas V, Casavilca S, Cano L, Sanchez J, Dunstan J, Calderon G, De La Cruz M, Cotrina JM, Gomez HL, Galvez R, Abugattas J.

Clin Transl Oncol. 2017 Dec;19(12):1478-1488. doi: 10.1007/s12094-017-1685-3. Epub 2017 Jun 2.


Acral Lentiginous Melanoma: Survival Analysis of 715 Cases.

Lino-Silva LS, Zepeda-Najar C, Salcedo-Hernández RA, Martínez-Said H.

J Cutan Med Surg. 2019 Jan/Feb;23(1):38-43. doi: 10.1177/1203475418800943. Epub 2018 Sep 15.


Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF.

J Clin Oncol. 2012 Jul 20;30(21):2678-83. doi: 10.1200/JCO.2011.37.8539. Epub 2012 Jun 18.


Acral lentiginous melanoma: histopathological prognostic features of 121 cases.

Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L.

Br J Dermatol. 2007 Aug;157(2):311-8. Epub 2007 Jun 26.


Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

Zhang YL, Li J, Mo HY, Qiu F, Zheng LM, Qian CN, Zeng YX.

Mol Cancer. 2010 Jan 10;9:4. doi: 10.1186/1476-4598-9-4.


The clinical significance of tumor-infiltrating lymphocytes and microscopic satellites in acral melanoma in a korean population.

Lee SJ, Lim HJ, Choi YH, Chang YH, Lee WJ, Kim DW, Yoon GS.

Ann Dermatol. 2013 Feb;25(1):61-6. doi: 10.5021/ad.2013.25.1.61. Epub 2013 Feb 14.


Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

Okabe M, Toh U, Iwakuma N, Saku S, Akashi M, Kimitsuki Y, Seki N, Kawahara A, Ogo E, Itoh K, Akagi Y.

Cancer Sci. 2017 Jan;108(1):81-90. doi: 10.1111/cas.13114. Epub 2017 Jan 21.


Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M.

J Clin Oncol. 2013 Nov 20;31(33):4252-9. doi: 10.1200/JCO.2013.51.3002. Epub 2013 Oct 14.


Expression of p16 protein in acral lentiginous melanoma.

Hsieh R, Firmiano A, Sotto MN.

Int J Dermatol. 2009 Dec;48(12):1303-7. doi: 10.1111/j.1365-4632.2008.04009.x.


Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.

Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL.

J Immunol. 1989 Nov 15;143(10):3404-11.


Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.

Wada M, Ito T, Tsuji G, Nakahara T, Hagihara A, Furue M, Uchi H.

J Dermatol. 2017 Aug;44(8):932-938. doi: 10.1111/1346-8138.13834. Epub 2017 Mar 24.


Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.

Krpina K, Babarović E, Jonjić N.

Virchows Arch. 2015 Oct;467(4):443-8. doi: 10.1007/s00428-015-1808-6. Epub 2015 Jul 28.


Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

West NR, Milne K, Truong PT, Macpherson N, Nelson BH, Watson PH.

Breast Cancer Res. 2011;13(6):R126. doi: 10.1186/bcr3072. Epub 2011 Dec 8.


CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.

Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, Nelson BH.

Clin Cancer Res. 2012 Jun 15;18(12):3281-92. doi: 10.1158/1078-0432.CCR-12-0234. Epub 2012 May 2.


Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.

Kim HJ, Seo JW, Roh MS, Lee JH, Song KH.

J Am Acad Dermatol. 2018 Oct;79(4):706-713. doi: 10.1016/j.jaad.2018.04.016. Epub 2018 Apr 16.


Long-term survival analysis and clinical follow-up in acral lentiginous malignant melanoma undergoing sentinel lymph node biopsy in korean patients.

Jeon SY, Hong JW, Lee S, Oh SY, Hong YS, Kim KH, Song KH.

Ann Dermatol. 2014 Apr;26(2):177-83. doi: 10.5021/ad.2014.26.2.177. Epub 2014 Apr 30.


Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.

Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S, Watanabe G, Tada H, Suzuki A, Ohuchi N, Ishida T.

Breast Cancer Res. 2015 Sep 4;17:124. doi: 10.1186/s13058-015-0632-x.


CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A.

Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.


Supplemental Content

Support Center